Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer
一项针对非肌层浸润性膀胱癌患者,采用重组腺病毒介导的Syn3制剂进行膀胱内灌注治疗的I期临床试验,旨在评估卡介苗治疗失败后的干扰素-α2b疗效。
期刊:Journal of Urology
影响因子:6.8
doi:10.1016/j.juro.2013.03.030
Dinney, Colin P N; Fisher, Mark B; Navai, Neema; O'Donnell, Michael A; Cutler, David; Abraham, Alice; Young, Sophia; Hutchins, Beth; Caceres, Maria; Kishnani, Narendra; Sode, George; Cullen, Constance; Zhang, Guangcheng; Grossman, H Barton; Kamat, Ashish M; Gonzales, Marshall; Kincaid, Michael; Ainslie, Nancy; Maneval, Daniel C; Wszolek, Matthew F; Benedict, William F